© 2 0 1 9 I n d I a n J o u r n a l o f P a t h o l o g y a n d M I c r o b I o l o g y | P u b l I s h e d b y W o l t e r s K l u W e r -M e d K n o W A 33-year-old male presented with a painful lesion in his index finger. He underwent radiologic imaging followed by a biopsy.
Magnetic resonance imaging (MRI) showed a well-defined punched out, mostly a soft tissue lesion, measuring 13 mm × 9.6 mm × 7.5 mm, involving the ventromedial aspect of base of the proximal phalanx. The lesion seemed expanding the volar cortex of the phalanx, scalloping the intact inner cortex, with a well-circumscribed soft tissue extension. It was heterogeneously hyperintense on T2-weighted image (T2WI), fat sat proton density (FSPD) and short tau inversion recovery (STIR) images and isointense on T1WI [ Figure 1b ]. The radiologic differentials were giant cell tumor and enchondroma protuberans.
Questions

What is the diagnosis?
Which category of tumors this entity comes under?
3. What is the recently described genetic event driving these group of tumors?
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Figure 1: (a) Plain radiograph showing a well-defined lesion, predominantly involving the soft tissues of the base of phalanx with peripheral ossification. (b) Magnetic resonance imaging showing a well-defined enhancing lesion. (c) Histopathologic findings. Lesion composed of fibroblastic cells in a myxoid stroma with reactive woven bone toward the periphery (H and E, ×200); (d) Fragments of woven bone lined by osteoblasts and osteoclasts within cellular fibroblastic stroma (H and E, ×200)
DISCUSSION
Solitary fibrous tumor (SFT) is defined as mesenchymal tumor of fibroblastic origin, which invariably displays a prominent hemangiopericytoma-like growth pattern and is composed of CD34-positive fibroblastic cells. The earlier term "hemangiopericytoma" has been replaced by a SFT. This tumor can occur at any body site, although commonly identified in the thoracic (pleural-based), head and neck, and other soft tissue sites. [1] While most SFTs display CD34 immunoexpression, certain cases might be negative. Moreover, CD34 positivity is seen in other tumors, such as a dermatofibrosarcoma protuberans, spindle cell lipoma; certain cases of gastrointestinal stromal tumor and nerve sheath tumors, which constitute as differential diagnoses of SFT in various locations. Synovial sarcoma and malignant peripheral nerve sheath tumors constitute as its other differentials.
Recently, signal transducer and activator of transcription (STAT)-6 has been identified as a single highly sensitive and a specific IHC marker for diagnosing a SFT, and almost a substitute for a specific fusion gene, NAB2-STAT6, which is the "molecular signature" underlying most SFTs. [2, 3] Although most SFTs are benign (unless classified as malignant), their behavior can be unpredictable. [1] Therefore, a model of risk stratification has been proposed for SFTs. [4] On that basis, the present case is low risk. Therefore, the patient has not been recommended any adjuvant therapy and is recommended a follow-up.
